358 related articles for article (PubMed ID: 32317186)
21. Knockdown of elF3a inhibits TGF‑β1‑induced extracellular matrix protein expression in keloid fibroblasts.
Li T; Zhao J
Mol Med Rep; 2018 Mar; 17(3):4057-4061. PubMed ID: 29286129
[TBL] [Abstract][Full Text] [Related]
22. Asiatic acid isolated from Centella asiatica inhibits TGF-β1-induced collagen expression in human keloid fibroblasts via PPAR-γ activation.
Bian D; Zhang J; Wu X; Dou Y; Yang Y; Tan Q; Xia Y; Gong Z; Dai Y
Int J Biol Sci; 2013; 9(10):1032-42. PubMed ID: 24250248
[TBL] [Abstract][Full Text] [Related]
23. Halofuginone regulates keloid fibroblast fibrotic response to TGF-β induction.
Marty P; Chatelain B; Lihoreau T; Tissot M; Dirand Z; Humbert P; Senez C; Secomandi E; Isidoro C; Rolin G
Biomed Pharmacother; 2021 Mar; 135():111182. PubMed ID: 33433355
[TBL] [Abstract][Full Text] [Related]
24. [Different effects of simvastatin on keloid fibroblasts under hypoxia and TGF-β1 treatment].
Chen B; Kang C; Yu D; Zhao X; An Y; Qin Z
Zhonghua Zheng Xing Wai Ke Za Zhi; 2016 Mar; 32(2):130-5. PubMed ID: 30024693
[TBL] [Abstract][Full Text] [Related]
25. Syndecan-1 regulates extracellular matrix expression in keloid fibroblasts via TGF-β1/Smad and MAPK signaling pathways.
Cui J; Jin S; Jin C; Jin Z
Life Sci; 2020 Aug; 254():117326. PubMed ID: 31954164
[TBL] [Abstract][Full Text] [Related]
26. TRAF3IP2 regulated by FOXO4 affects fibroblast proliferation, migration, and extracellular matrix deposition in keloid through the TGF-β1/Smad pathway.
Yan Q; Li B
J Cosmet Dermatol; 2022 Oct; 21(10):5148-5155. PubMed ID: 35441794
[TBL] [Abstract][Full Text] [Related]
27. Mast cell chymase in keloid induces profibrotic response via transforming growth factor-β1/Smad activation in keloid fibroblasts.
Dong X; Zhang C; Ma S; Wen H
Int J Clin Exp Pathol; 2014; 7(7):3596-607. PubMed ID: 25120737
[TBL] [Abstract][Full Text] [Related]
28. Keloid Core Factor CTRP3 Overexpression Significantly Controlled TGF-
He L; Zhu C; Dou H; Yu X; Jia J; Shu M
Dis Markers; 2023; 2023():9638322. PubMed ID: 37091895
[TBL] [Abstract][Full Text] [Related]
29. CUDC‑907 reverses pathological phenotype of keloid fibroblasts in vitro and in vivo via dual inhibition of PI3K/Akt/mTOR signaling and HDAC2.
Tu T; Huang J; Lin M; Gao Z; Wu X; Zhang W; Zhou G; Wang W; Liu W
Int J Mol Med; 2019 Nov; 44(5):1789-1800. PubMed ID: 31545402
[TBL] [Abstract][Full Text] [Related]
30. Troglitazone suppresses transforming growth factor-beta1-induced collagen type I expression in keloid fibroblasts.
Zhang GY; Yi CG; Li X; Ma B; Li ZJ; Chen XL; Guo SZ; Gao WY
Br J Dermatol; 2009 Apr; 160(4):762-70. PubMed ID: 19120328
[TBL] [Abstract][Full Text] [Related]
31. Increased Cthrc1 Activates Normal Fibroblasts and Suppresses Keloid Fibroblasts by Inhibiting TGF-β/Smad Signal Pathway and Modulating YAP Subcellular Location.
Zhao MJ; Chen SY; Qu XY; Abdul-Fattah B; Lai T; Xie M; Wu SD; Zhou YW; Huang CZ
Curr Med Sci; 2018 Oct; 38(5):894-902. PubMed ID: 30341526
[TBL] [Abstract][Full Text] [Related]
32. Calcimycin Suppresses S100A4 Expression and Inhibits the Stimulatory Effect of Transforming Growth Factor β1 on Keloid Fibroblasts.
Zhao YX; Ho CK; Xie Y; Chen YH; Li HZ; Zhang GY; Li QF
Ann Plast Surg; 2018 Aug; 81(2):163-169. PubMed ID: 29846215
[TBL] [Abstract][Full Text] [Related]
33. Pirfenidone suppresses TGF‑β1‑induced human intestinal fibroblasts activities by regulating proliferation and apoptosis via the inhibition of the Smad and PI3K/AKT signaling pathway.
Sun Y; Zhang Y; Chi P
Mol Med Rep; 2018 Oct; 18(4):3907-3913. PubMed ID: 30152848
[TBL] [Abstract][Full Text] [Related]
34. Oleanolic acid regulates the proliferation and extracellular matrix of keloid fibroblasts by mediating the TGF-β1/SMAD signaling pathway.
Luo Y; Wang D; Yuan X; Jin Z; Pi L
J Cosmet Dermatol; 2023 Jul; 22(7):2083-2089. PubMed ID: 36847714
[TBL] [Abstract][Full Text] [Related]
35. Nintedanib inhibits keloid fibroblast functions by blocking the phosphorylation of multiple kinases and enhancing receptor internalization.
Zhou BY; Wang WB; Wu XL; Zhang WJ; Zhou GD; Gao Z; Liu W
Acta Pharmacol Sin; 2020 Sep; 41(9):1234-1245. PubMed ID: 32327724
[TBL] [Abstract][Full Text] [Related]
36. TIEG1 Represses Smad7-Mediated Activation of TGF-β1/Smad Signaling in Keloid Pathogenesis.
Hu ZC; Shi F; Liu P; Zhang J; Guo D; Cao XL; Chen CF; Qu SQ; Zhu JY; Tang B
J Invest Dermatol; 2017 May; 137(5):1051-1059. PubMed ID: 28108300
[TBL] [Abstract][Full Text] [Related]
37. Oxymatrine inhibits collagen synthesis in keloid fibroblasts via inhibition of transforming growth factor-β1/Smad signaling pathway.
Fan DL; Zhao WJ; Wang YX; Han SY; Guo S
Int J Dermatol; 2012 Apr; 51(4):463-72. PubMed ID: 22435440
[TBL] [Abstract][Full Text] [Related]
38. NADPH oxidase-2 is a key regulator of human dermal fibroblasts: a potential therapeutic strategy for the treatment of skin fibrosis.
Zhang GY; Wu LC; Dai T; Chen SY; Wang AY; Lin K; Lin DM; Yang JQ; Cheng B; Zhang L; Gao WY; Li ZJ
Exp Dermatol; 2014 Sep; 23(9):639-44. PubMed ID: 24981855
[TBL] [Abstract][Full Text] [Related]
39. Gallic acid inhibits fibroblast growth and migration in keloids through the AKT/ERK signaling pathway.
Wang X; Liu K; Ruan M; Yang J; Gao Z
Acta Biochim Biophys Sin (Shanghai); 2018 Nov; 50(11):1114-1120. PubMed ID: 30265275
[TBL] [Abstract][Full Text] [Related]
40. Profibrogenic effect of high-mobility group box protein-1 in human dermal fibroblasts and its excess in keloid tissues.
Lee WJ; Song SY; Roh H; Ahn HM; Na Y; Kim J; Lee JH; Yun CO
Sci Rep; 2018 May; 8(1):8434. PubMed ID: 29849053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
